Skip navigation

Tennessee victims in U.S. meningitis outbreak win new avenue for lawsuits

BOSTON (Reuters) - Victims in Tennessee of a deadly U.S. meningitis outbreak won the right to pursue a new avenue of litigation against healthcare facilities and doctors there, after a ruling by a U.S. bankruptcy judge this week. Full story

Senate committee advances drug compounding bill

NEW YORK (Reuters) - A U.S. Senate committee on Wednesday unanimously approved legislation that would increase federal oversight for companies that compound and sell sterile drugs across state lines. Full story

FDA chief grilled on meningitis outbreak as new documents emerge

WASHINGTON (Reuters) - The head of the U.S. Food and Drug Administration conceded on Tuesday that the agency could have been more aggressive in its oversight of the compounding pharmacy at the center of a deadly meningitis outbreak. Full story

Michigan official seeks grand jury to probe meningitis outbreak

LANSING, Mich (Reuters) - Michigan's attorney general on Tuesday asked state courts to authorize a grand jury to investigate whether a company linked to a deadly outbreak of fungal meningitis and other infections broke any state laws. Full story

Congress panel to probe meningitis deaths

   The co-owner of the NECC pharmacy tied to the deadly meningitis outbreak has refused to answer questions, leaving federal and state regulators to explain why they allowed a business with a checkered history to keep making drugs. NBC’s Lisa Meyers reports.

‘Specialty pharmacies’ come under microscope

   Specialized pharmacies that mix individual solutions and creams have been blamed for the recent meningitis outbreak. NBC’s Lisa Myers finds out that this isn’t the first time safety concerns have been raised; since 2004, the FDA has issued 49 warning letters to compounding pharmacies.

Sponsored Links
advertisement | ad info